JNVIX
Price
$17.52
Change
+$0.14 (+0.81%)
Updated
Aug 21 closing price
Net Assets
91.34M
VEXAX
Price
$186.29
Change
+$1.58 (+0.86%)
Updated
Aug 21 closing price
Net Assets
93.63B
Interact to see
Advertisement

JNVIX vs VEXAX

JNVIX vs VEXAX Comparison Chart in %
View a ticker or compare two or three
VS
JNVIX vs. VEXAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNVIX is a Buy and VEXAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 93.6B vs. JNVIX (91.3M). VEXAX pays higher dividends than JNVIX: VEXAX (1.03) vs JNVIX (0.57). JNVIX was incepted earlier than VEXAX: JNVIX (16 years) vs VEXAX (26 years). JNVIX (0.88) is less costly to investors than VEXAX (0.05). JNVIX is a more actively managed with annual turnover of: 24.87 vs. VEXAX (12.00). VEXAX has a lower initial minimum investment than JNVIX: VEXAX (3000) vs JNVIX (250000). VEXAX annual gain was more profitable for investors over the last year : 23.89 vs. JNVIX (-8.20). VEXAX return over 5 years is better than : 36.15 vs. JNVIX (0.84).
JNVIXVEXAXJNVIX / VEXAX
Total Expense Ratio0.820.051,640%
Annual Report Gross Expense Ratio0.880.051,760%
Fund Existence16 years26 years-
Gain YTD7.24517.62641%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets91.3M93.6B0%
Annual Yield % from dividends0.571.0356%
Returns for 1 year-8.2023.89-34%
Returns for 3 years7.8869.8111%
Returns for 5 years0.8436.152%
Returns for 10 years58.34178.6333%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMFIX18.200.31
+1.73%
Ashmore Emerging Markets Equity Instl
MGRVX51.070.53
+1.05%
MFS International Growth R4
CSVGX49.390.41
+0.84%
Columbia Select Large Cap Value S
AFOYX20.860.17
+0.82%
Ariel Focus Institutional
MCRFX15.460.11
+0.72%
BlackRock Mid-Cap Value Investor C